Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

6.665
-0.305-4.38%
Volume:4.46M
Turnover:30.31M
Market Cap:2.53B
PE:-7.14
High:7.105
Open:6.775
Low:6.660
Close:6.970
52wk High:22.560
52wk Low:5.350
Shares:380.07M
HK Float Shares:375.46M
Volume Ratio:1.03
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.934
ROE:-70.66%
ROA:-28.19%
PB:8.32
PE(LYR):-7.14
PS:20288.32

Loading ...

TYK Medicines Extends Long-Stop Date for 63.22 Million H-Share Placement to 20 September 2026

Bulletin Express
·
Aug 20

Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up

Stock News
·
Aug 18

TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward

Stock News
·
Aug 17

TYK Medicines outlines 2026 board reshuffle, schedules vote on seven director re-elections

Bulletin Express
·
Aug 17

TYK Medicines FY26 H1 Comprehensive Loss Narrows 76.4% to RMB 26.88 Million

Reuters
·
Aug 17

TYK Medicines Files List of Directors, Board Committee Memberships and Disclosure-Responsible Management

Reuters
·
Aug 17

TYK Medicines Non-Executive Director Jiang Mingyu Resigns, Wu Yusheng Named Authorized Representative

Reuters
·
Aug 17

TYK Medicines Sets 17 August 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend

Bulletin Express
·
Aug 05

TYK Medicines Reports No Share Capital Changes in July 2026 Monthly Return

Bulletin Express
·
Aug 05

TYK Medicines Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 05

TYK Medicines-B Shares Surge Over 5% as Qilu Pharma Secures Exclusive Rights for Lung Cancer Drug TY-9591

Deep News
·
Jul 27

TYK Medicines files dual court actions to invalidate alleged TY-9591 agreements with Sichuan Huiyu Pharmaceutical

Bulletin Express
·
Jul 22

TYK MEDICINES-B Initiates Legal Proceedings Against Sichuan Huiyu Pharmaceutical Co., Ltd.

Stock News
·
Jul 22

Tyk Medicines - Files Legal Proceedings Against Sichuan Huiyu Pharmaceutical over Ty-9591 Agreements

THOMSON REUTERS
·
Jul 22

TYK Medicines Sues Huiyu Pharma over Disputed Ty-9591 Cooperation Deal

Reuters
·
Jul 22

Strategic Collaboration Sees Qilu Invest RMB 400 Million in TYK MEDICINES-B for TY-9591 Development and Commercialization

Stock News
·
Jul 21

TYK Medicines Prices Private Placement of 63,222,744 H Shares at HK$ 7.3 Each

Reuters
·
Jul 21

Tyk Medicines - to Receive Aggregate Upfront Payment of Rmb700 Mln Plus Potential Milestone Payments

THOMSON REUTERS
·
Jul 21

Tyk Medicines - Co Enters License and Collaboration Agreement with Qilu for Ty-9591 in China

THOMSON REUTERS
·
Jul 21

Hong Kong Shares Surge: TYK MEDICINES-B Soars Over 15% in Afternoon Trading on Key Drug Trial Results

Stock News
·
Jul 21